1-4 of 4
Noel Blake
Close
Sort by
Journal Articles

Mcl-1 Dependence Predicts Response To Vorinostat and Gemtuzumab Ozogamicin In Acute Myeloid Leukemia

William E. Pierceall, PhD, Ryan Lena, BS, Bruno C. Medeiros, MD, Elihu H. Estey, MD, Noel Blake, B.S., Michael Elaschoff, Ph.D., Michael Cardone, PhD, Roland B. Walter, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1305.
https://doi.org/10.1182/blood.V122.21.1305.1305
Published: 2013
Journal Articles

BH3 Profiling As Predictor Of 5-Azacytidine and Decitabine Clinical Responses

Raoul Tibes, MD, PhD, Steven M. Kornblau, MD, William E. Pierceall, PhD, Ryan Lena, BS, Yi Hua Qiu, MD, Michael Cardone, PhD, Leena Chaudhuri, PhD, Veena Fauble, MD, Michael Elashoff, Noel Blake, B.S., Ruben A. Mesa, MD, James M Bogenberger, PhD
Journal: Blood
Blood (2013) 122 (21): 603.
https://doi.org/10.1182/blood.V122.21.603.603
Published: 2013
Journal Articles

Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656

Brief Report
Brian J. Lannutti, Noel Blake, Manish J. Gandhi, Jo Anna Reems, Jonathan G. Drachman
Journal: Blood
Blood (2005) 105 (10): 3875–3878.
https://doi.org/10.1182/blood-2004-10-3934
Published: 2005
Journal Articles

Induction of Polyploidization in Leukemic Cell Lines and Primary Bone Marrow by Src Kinase Inhibitor SU6656.

Brian J. Lannutti, PhD, Jennifer N. Minear, BS, Noel Blake, BS, Jonathan G. Drachman, MD
Journal: Blood
Blood (2004) 104 (11): 2918.
https://doi.org/10.1182/blood.V104.11.2918.2918
Published: 2004